Company News »

Simulations Plus to Present at B. Riley 16th Annual Investor Conference

Business Wire
Share on StockTwits
Published on

Simulations Plus, Inc. (NASDAQ:SLP) , a leading provider of consulting services and software for pharmaceutical discovery and development, will be presenting at the 16th Annual B. Riley & Co. Investor Conference on Tuesday, May 12, 2015, in Los Angeles, California. Walt Woltosz, chairman and CEO, will be presenting at 11:30 a.m. Pacific Time in the Elysian Park room of the Loews Hollywood Hotel.

Simulations Plus management will be available during the day for one-on-one meetings. To schedule a meeting, please contact your B. Riley representative. A copy of the investor presentation that will accompany management’s group presentation will be available at the Simulations Plus corporate website – – prior to the presentation.

About B. Riley

B. Riley & Co., LLC (B. RILEY) is a leading, independent, investment bank which provides a full array of corporate finance, research, and sales & trading to corporate, institutional, and high net worth individual clients. Investment banking services include initial, secondary, and follow-on offerings, institutional private placements, and merger and acquisitions advisory to public and private middle-market companies. The firm is nationally recognized for its highly ranked proprietary equity research. Founded in 1997, B. RILEY is headquartered in Los Angeles and maintains offices in: New York, San Francisco, and Newport Beach, California. It is a member of FINRA and SIPC. For more information, please visit

About Simulations Plus, Inc.

Simulations Plus, Inc. is a premier developer of groundbreaking drug discovery and development simulation and modeling software which is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide. Simulations Plus also recently acquired Cognigen Corporation of Buffalo, New York, adding top-quality statistical modeling and simulation using clinical trial data to its offerings, as well as more than doubling their staff from 30 to over 60, adding nearly 50% to revenues, and increasing earnings in the fiscal year that began September 1, 2014. The Company is headquartered in Southern California and trades on the NASDAQ Capital Market under the symbol “SLP.” Cognigen Corporation remains located in Buffalo, NY. For more information, visit our web site at

Share on StockTwits